News

Displaying 1 - 20 of 645

Save the date: European Drug Report 2021 to be released on 9 June

20.05.2021

How has the COVID-19 pandemic affected drug use and supply? What drugs are causing the most concern today? What are the latest trends in drug production and trafficking? Find out more when the EU drugs agency (EMCDDA) launches its European Drug Report 2021: Trends and Developments in a live online...

Latest wastewater data reveal drug-taking habits in a record 82 European cities

18.05.2021

The 2020 findings from the largest European project in the science of wastewater analysis are revealed today in Wastewater analysis and drugs — a European multi-city study, published by the Europe-wide SCORE group, in association with the EU drugs agency (EMCDDA) (1)(2). The project analysed...

Legalisation of cannabis in 3 US states: New York, Virginia, New Mexico

04.05.2021

In the last few weeks, three US states have legalised cannabis for recreational purposes, all via the legislature and not via public ballots. New York, Virginia and New Mexico will begin by permitting cannabis use in private and home cultivation, for adults aged over 21 (out of sight and away from...

EMCDDA launches its first bilateral technical cooperation project with Georgia

03.05.2021

The EMCDDA has launched today its first bilateral technical cooperation project with Georgia aimed at enhancing national responses to drug-related health and security threats. The EMCDDA4Georgia project (EMCDDA4GE) will focus primarily on knowledge transfer and capacity-building in the areas of...

EMCDDA releases third trendspotter study on COVID-19 and drugs

30.04.2021

The EMCDDA releases today the third in a series of rapid ‘trendspotter’ studies exploring the impact of COVID-19 on the drug situation and responses to it. Revisiting and reviewing findings from two studies in 2020 on the effects of the pandemic on drug use and services, the report identifies new...

Austrian Minister for the EU and Constitution visits the EMCDDA

23.04.2021

Austrian Federal Minister for the European Union and Constitution Karoline Edtstadler, visits the EMCDDA today where she will meet EMCDDA Director Alexis Goosdeel. The Minister will receive a briefing on the agency’s ongoing activities under EMCDDA Strategy 2025 and how it contributes to a...

News from EU4Monitoring Drugs, an EMCDDA technical cooperation project

16.04.2021

This content was published in the EU4MD update released on 16.04.2020. This update also presents a section on partnerships, annoucements, studies, upcoming events, and a research corner. Focus on: Methamphetamine trade in Iran This report builds on the study published by the EMCDDA on the Afghan...

EMCDDA Best practice portal update (2/2021)

15.04.2021

School-based programmes to improve mental health and well-being and reduce risks Adolescents spend a significant part of their lifetime in school and, therefore, this environment plays an important role in their social, emotional and psychological development. Psychological distress can appear...

Commissioner Johansson acknowledges value of EMCDDA analysis in informing drug policy

12.04.2021

European Commissioner for Home Affairs Ylva Johansson paid her first visit to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) today during a day of events relating to the fight against organised crime. EMCDDA Director Alexis Goosdeel welcomed the Commissioner to the agency for...

EMCDDA launches 2021 European Web Survey on Drugs to assess patterns of drug use in over 30 countries

18.03.2021

Do you use drugs? How many? How often? These are among the questions posed in the latest European Web Survey on Drugs, launched today by the EU drugs agency (EMCDDA). Targeted at people, aged 18 and over, who have used drugs, the survey aims to improve understanding of patterns of drug use in...

European Commission proposes to control two harmful new psychoactive substances

12.03.2021

Today, the European Commission has proposed to control two harmful new psychoactive substances (NPS) across the European Union. The substances in question — MDMB-4en-PINACA and 4F-MDMB-BICA — are both synthetic cannabinoids, which have been raising health concerns in Europe (1). The proposal to...

New multi-city syringe study uncovers latest patterns of injecting drug use

17.02.2021

The latest patterns of injecting drug use in a selection of European cities are explored today in a new study from the EMCDDA. The report presents the results of an innovative project investigating the substances used by people who inject drugs, by chemically analysing the content of used syringes...

Maximising access to drug treatment while minimising diversion of medications — new EMCDDA report looks at striking the balance

11.02.2021

Opioid substitution treatment (OST) is a key evidence-based tool used to manage opioid dependence and improve related health and social consequences. Yet increasing reports of the diversion and misuse of the controlled drugs used in this treatment in Europe are a cause for concern. In a new report...

EMCDDA enters new phase as it embarks on 2021 activities

29.01.2021

This year, the EMCDDA will embark on a new five-year Roadmap under its Strategy 2025, kicking off with an ambitious range of activities for the period 2021–23. We enter this new phase amid major uncertainty, when the long-term impact of the COVID-19 pandemic remains largely unknown. In such times,...

EU presidency: Portugal focuses on Europe’s recovery and chairs activities in the field of drugs

28.01.2021

This month, Portugal took over the rotating presidency of the Council of the EU with the motto ‘Time to deliver: a fair, green and digital recovery’. Over the next six months, Portugal will lead work at all levels of the Council, building co-operation, agreement and solidarity between EU Member...

EMCDDA kicks off new wave of webinars for 2021

27.01.2021

The EMCDDA will be kicking off its 2021 programme of webinars on 3 February starting with the topic ‘Responding to drugs and homelessness: innovative approaches in Europe’. The link between long-term homelessness, problem drug use and alcohol dependence is well documented. As the COVID-19 pandemic...

Bursaries for students from European Neighbourhood Policy countries for the 2021 European Drugs Winter and Summer Schools

26.01.2021

Professionals, academics or experts from European Neighbourhood Policy (ENP) countries (1) will have an opportunity to participate in the European Drugs Winter and Summer Schools this year, thanks to 10 bursaries being offered through the EU4Monitoring Drugs (EU4MD) project. The University...

Bursaries for Western Balkan students for the 2021 European Drugs Winter School

25.01.2021

Professionals, academics and experts from the Western Balkan region will have an opportunity to participate in the first European Drugs Winter School (EDWS) this year, thanks to six bursaries being offered through the EMCDDA Instrument for Pre-accession Assistance project (IPA 7). The course,...

Euro-DEN Plus network prepares to expand beyond the EU

11.01.2021

Data from hospital emergency departments show that every year in Europe thousands of individuals experience drug-related toxicity and other harms, resulting in emergency presentations to hospital (1). Supported by the EMCDDA, the European Drug Emergencies Network (Euro-DEN Plus) monitors drug-...

Message from EMCDDA Director, Alexis Goosdeel

08.01.2021

In this first week of the new year, I would like to thank you for your continued support and wish you a very happy 2021. Ringing in the new year may have felt a little different this time as we reflected on the trials of the past 12 months. Yet in many ways, we have emerged strengthened and...
Loading